Scientific article
Case report
Open access

Orbital myositis induced by alendronate: A case report

Published inEuropean journal of neurology, vol. 30, no. 6, p. 1828-1830
Publication date2023-06
First online date2023-03-07

Background and purpose: Bisphosphonates are widely used, notably for osteoporosis treatment. Their common side effects are well known. However, they can trigger less common effects such as orbital inflammation. Here, the case is reported of an orbital myositis triggered by alendronate.

Methods: This is a case report at an academic medical center. An orbital magnetic resonance imaging scan, a thoraco-abdominal computed tomography scan and blood sample analyses were performed.

Results: A 66-year-old woman treated by alendronate for her osteoporosis was investigated. She developed an orbital myositis after the first intake. Neurological examination revealed a painful diplopia with decreased downward and adduction movements of the right eye and edema of the upper eyelid. Orbital magnetic resonance imaging showed an orbital myositis of the right eye. No other cause of orbital myositis was found than the alendronate intake. After alendronate arrest and a short course of prednisone, the symptoms resolved.

Conclusion: This case highlights that alendronate can cause an orbital myositis whose early diagnosis is of major importance because it is a treatable side effect.

  • Alendronate
  • Bisphosphonates
  • Orbital inflammation
  • Orbital myositis
Citation (ISO format)
LEFEUVRE, Lucie et al. Orbital myositis induced by alendronate: A case report. In: European journal of neurology, 2023, vol. 30, n° 6, p. 1828–1830. doi: 10.1111/ene.15772
Main files (1)
Article (Published version)
ISSN of the journal1351-5101

Technical informations

Creation03/30/2023 11:42:05 AM
First validation07/05/2023 4:57:21 PM
Update time07/05/2023 4:57:21 PM
Status update07/05/2023 4:57:21 PM
Last indexation08/31/2023 11:55:35 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack